LASER DEEP SCLERECTOMY (LDS)

Vassilios P. Kozobolis, Emmanouil Christodoulakis and Ioannis G. Pallikaris

Glaucoma Unit, Department of Opthalmology, University of Crete & VEIC, Greece

Purpose: The formation of a filtrative area, using the Erbium Yag Laser, over the trabeculum, the Schlemm’s canal and the Descemet’s membrane, in order to permit the percolation of acqueous humor from the anterior chamber to the subconjunctival space

Setting: We use the CentauriTM Erbium Yag-laser (Premiere), solid state  - 2940 nm

Pulse Rate: 10 - 30 Hz, Output Energy: -250 mJ at 10 Hz, Pulse Width: 300 μsec, Aiming Beam: Green Helium Neon Laser

Methods: Forty five eyes of 45 patients (26 males and 19 females) suffered from POAG and PEXG underwent the LDS

(Thickness of superficial scleral flap: 250μ, Size of  sup. scleral flap: 5mm X 5mm, Size of  photoablated area: 4mm X 4mm, Repetition rate:10 Hz & Energy: 10mJ)

Results: The IOP was decreased from 26.37 + 3.41 to 16.54 + 3.55 mmHg in a follow – up period of 13.34 + 5.70 months (3 – 18months). The mean number of medication was also decreased from 2.88 + 0.71 drugs to 1.18 + 0.80. Concerning the complications, choroidal detachment was found in  13.33%, hypheama in 11.11%, leakage in 1 eye, cystic bleb or bleb fibrosis in 17.14%

Conclusions: LS (Laser Sclerectomy) is a new and safe surgical procedure for Glaucoma treatment. The scleral and the corneal ablation are performed in a step by step fashion but microperforations could be created. The healing process could be influenced by the application of Erbium Yag laser. A longer follow up is required; in our view the problem to be resolved, as in all antiglaucoma surgical procedures will be the healing process.